Search

everythinglearnresearchcommunity

for

Search:↓

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

CIP/KIP proteins help stop cell division and support hair growth.

Hair transplant combining scalp and beard hair with PRP was successful for scarring alopecia.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

People with non-scarring hair loss have higher levels of DKK-1, a protein linked to hair growth, than those with scarring hair loss or no hair loss.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

Sarcoidosis can cause scarring hair loss on the scalp, which is rare.

Fat tissue and a specific protein are crucial for healthy hair growth and maintenance.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Hair transplants can work for permanent hair loss if the condition is stable and done carefully.

Adding platelet rich plasma to hair transplant surgery leads to better results and more patient satisfaction.

Hair loss due to a repaired brain bulge was successfully treated using a tissue expansion technique.

Dermoscopy is a useful, low-cost method for diagnosing various types of hair loss disorders known as Cicatricial Alopecia.

People with Primary Cicatricial Alopecia have a higher risk of heart disease.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Scaffold-based strategies show promise for regenerating hair follicles and teeth but need more research for clinical use.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Autologous fat transfer improves hair growth in scarring alopecia and allows for denser hair transplants.

Autologous FUE hair transplantation is effective and safe for treating hair loss due to scarring from infections.

A woman developed permanent hair loss after a face-lift surgery despite various treatments.

Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.

Both follicular unit extraction and scalp expanders effectively treat secondary cicatricial alopecia, with scalp expanders leading to quicker and denser hair growth.

Tissue expansion is a safe primary method for hair restoration in patients with large scalp defects before hair transplantation.

Advancements in tissue engineering show promise for hair follicle regeneration to treat hair loss.